These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34634916)

  • 1. Ligand-based design of anticancer MMP2 inhibitors: a review.
    Sanyal S; Amin SA; Adhikari N; Jha T
    Future Med Chem; 2021 Nov; 13(22):1987-2013. PubMed ID: 34634916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.
    Yan XQ; Wang ZC; Li Z; Wang PF; Qiu HY; Chen LW; Lu XY; Lv PC; Zhu HL
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4664-71. PubMed ID: 26346367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-Activity Relationships of UTX-121 Derivatives for the Development of Novel Matrix Metalloproteinase-2/9 Inhibitors.
    Yamahana H; Komiya Y; Takino T; Endo Y; Yamada H; Asada C; Uto Y
    Chem Pharm Bull (Tokyo); 2021; 69(10):1017-1028. PubMed ID: 34602570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and preliminary evaluation of α-sulfonyl γ-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.
    Zhang J; Li X; Jiang Y; Feng J; Li X; Zhang Y; Xu W
    Bioorg Med Chem; 2014 Jun; 22(11):3055-64. PubMed ID: 24755524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, Biological Evaluation, and Docking of Dihydropyrazole Sulfonamide Containing 2-hydroxyphenyl Moiety: A Series of Novel MMP-2 Inhibitors.
    Wang PF; Qiu HY; Baloch SK; Gong HB; Wang ZC; Zhu HL
    Chem Biol Drug Des; 2015 Dec; 86(6):1405-10. PubMed ID: 26061284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered s-Triazine-Based Dendrimer-Honokiol Conjugates as Targeted MMP-2/9 Inhibitors for Halting Hepatocellular Carcinoma.
    Khalil HH; Osman HA; Teleb M; Darwish AI; Abu-Serie MM; Khattab SN; Haiba NS
    ChemMedChem; 2021 Dec; 16(24):3701-3719. PubMed ID: 34547831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pentanoic acid derivative targeting matrix metalloproteinase-2 (MMP-2) induces apoptosis in a chronic myeloid leukemia cell line.
    Mukherjee A; Adhikari N; Jha T
    Eur J Med Chem; 2017 Dec; 141():37-50. PubMed ID: 29028530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Halting colorectal cancer metastasis via novel dual nanomolar MMP-9/MAO-A quinoxaline-based inhibitors; design, synthesis, and evaluation.
    Ayoup MS; Abu-Serie MM; Awad LF; Teleb M; Ragab HM; Amer A
    Eur J Med Chem; 2021 Oct; 222():113558. PubMed ID: 34116327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted MMP-2 responsive chimeric polymersomes for therapy against colorectal cancer.
    Ramezani P; Abnous K; Taghdisi SM; Zahiri M; Ramezani M; Alibolandi M
    Colloids Surf B Biointerfaces; 2020 Sep; 193():111135. PubMed ID: 32447200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of Novel Hybrids Inspired from Bromopyrrole Alkaloids Inhibiting MMP-2 and -12 as Antineoplastic Agents.
    Rane RA; Naphade SS; Bangalore PK; Palkar MB; Patel HM; Shaikh MS; Alwan WS; Karpoormath R
    Chem Biol Drug Des; 2015 Aug; 86(2):210-22. PubMed ID: 25418204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Battle tactics against MMP-9; discovery of novel non-hydroxamate MMP-9 inhibitors endowed with PI3K/AKT signaling attenuation and caspase 3/7 activation via Ugi bis-amide synthesis.
    Ayoup MS; Fouad MA; Abdel-Hamid H; Ramadan ES; Abu-Serie MM; Noby A; Teleb M
    Eur J Med Chem; 2020 Jan; 186():111875. PubMed ID: 31740054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and preliminary bioactivity evaluations of 8-hydroxyquinoline derivatives as matrix metalloproteinase (MMP) inhibitors.
    Chen C; Yang X; Fang H; Hou X
    Eur J Med Chem; 2019 Nov; 181():111563. PubMed ID: 31415980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.
    Adhikari N; Halder AK; Mallick S; Saha A; Saha KD; Jha T
    Bioorg Med Chem; 2016 Sep; 24(18):4291-4309. PubMed ID: 27452283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Evaluation of A New Series of Thiazole Derivatives as Potential Antitumor Agents and MMP Inhibitors.
    Kaplancikli ZA; Altıntop MD; Atli O; Sever B; Baysal M; Temel HE; Demirci F; Ozdemir A
    Anticancer Agents Med Chem; 2017; 17(5):674-681. PubMed ID: 27491937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress towards water-soluble triazole-based selective MMP-2 inhibitors.
    Fabre B; Filipiak K; Zapico JM; Díaz N; Carbajo RJ; Schott AK; Martínez-Alcázar MP; Suárez D; Pineda-Lucena A; Ramos A; de Pascual-Teresa B
    Org Biomol Chem; 2013 Oct; 11(38):6623-41. PubMed ID: 23989288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivatives of D(-) glutamine-based MMP-2 inhibitors as an effective remedy for the management of chronic myeloid leukemia-Part-I: Synthesis, biological screening and in silico binding interaction analysis.
    Das S; Mondal S; Patel T; Himaja A; Adhikari N; Banerjee S; Baidya SK; De AK; Gayen S; Ghosh B; Jha T
    Eur J Med Chem; 2024 Aug; 274():116563. PubMed ID: 38843586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico study combining docking and QSAR methods on a series of matrix metalloproteinase 13 inhibitors.
    Xi L; Li S; Yao X; Wei Y; Li J; Liu H; Wu X
    Arch Pharm (Weinheim); 2014 Nov; 347(11):825-33. PubMed ID: 25363411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of novel benzofuroxan-based pyrrolidine hydroxamates as matrix metalloproteinase inhibitors with nitric oxide releasing activity.
    Zhang H; Wang X; Mao J; Huang Y; Xu W; Duan Y; Zhang J
    Bioorg Med Chem; 2018 Aug; 26(15):4363-4374. PubMed ID: 30093347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring natural anthraquinones as potential MMP2 inhibitors: A computational study.
    Jamshidi S; Rostami A; Shojaei S; Taherkhani A; Taherkhani H
    Biosystems; 2024 Jan; 235():105103. PubMed ID: 38123060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New bifunctional metalloproteinase inhibitors: an integrated approach towards biological improvements and cancer therapy.
    Marques SM; Abate CC; Chaves S; Marques F; Santos I; Nuti E; Rossello A; Santos MA
    J Inorg Biochem; 2013 Oct; 127():188-202. PubMed ID: 23597851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.